Geneva Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Geneva Advisors's CL Position: Q2 2017 in Review
Geneva Advisors reduced its Colgate-Palmolive (CL) stake by 2.7% in Q2 2017, selling an estimated $36.7K and leaving 17,557 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #311.
Geneva Advisors first reported a position in CL in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.55M in Q3 2014. 1,370 funds tracked by Wall St. Rank hold CL as of Q2 2017.
- Geneva Advisors held 17,557 shares of Colgate-Palmolive worth $1.3M as of Q2 2017.
- Geneva Advisors sold 494 Colgate-Palmolive shares in Q2 2017, an estimated $36.7K.
- Colgate-Palmolive made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #311 holding.
- Geneva Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 17 quarters since.
- Geneva Advisors's Colgate-Palmolive position peaked at $1.55M in Q3 2014.
- 1,370 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.